Interv Akut Kardiol. 2003;2(4):184-189

Prehospital thrombolysis

Stanislav Janoušek
Interní kardiologická klinika FN a LF MU v Brně

The interval from onset of symptoms to the start of treatment in acute myocardial infarction (AMI) is substantially shortened by using prehospital thrombolysis. The cumulative analysis of studies comparing prehospital and hospital thrombolysis proves statistically significant reduction of short-time and long-time mortality in prehospital thrombolysis. That profit is similar to primary percutaneous transluminal coronary angioplasty (PTCA) in comparison with hospital thrombolysis. The basic problem is record of 12leads ECG and its interpretation since thrombolysis is indicated only in the presence of ST segment elevation or recent bundle branch block. Besides training of personnel providing prehospital management is a modern alternative ECG record transmission by radio signal into specialized center of acute care (coronary care unit, intensive care unit) and their interpretation by a specialist. There are two main indications of prehospital thrombolysis. Firstly, if the transport to the hospital is longer than 60–90 min. Secondly, up to now neglected possibility, if the patients had their first contact with medical assistance during the first two hours after the onset of symptoms (Golden Hours). It is necessary to use modern thrombolytics that have shorter half-time and can be administered in the bolus (tissue plasminogen activator, reteplase, tenecteplase). Besides a shorter application time their main advantage is the possibility of combination with the following PTCA. In this respect we find basic problem limiting development of prehospital thrombolysis in the Czech Republic, which is limited financial resources since of new thrombolytics are quite expensive.

In spite of many unresolved problems the prehospital thrombolysis seems to be a hopeful strategy for the reduction of mortality in patients with AMI especially by possible combination with the following PTCA. This strategy is being verified at present in several randomized studies.

Keywords: Acute myocardial infarction, reperfusion therapy, prehospital thrombolysis.

Published: December 31, 2003  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Janoušek S. Prehospital thrombolysis. Interv Akut Kardiol. 2003;2(4):184-189.
Download citation

References

  1. Rackley CE, Russell ROJ, Mantel JA, et al. Modern approach to the patient with acute myocardial infarction. Curr Probl Cardiol 1977; 1: 1-47. Go to original source... Go to PubMed...
  2. Grines CL, Browne KF, Marco J, et al. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl. J Med 1993; 328: 673-679. Go to original source... Go to PubMed...
  3. Stone GW, Brodie BR, Griffin JJ, et al. Prospective, multicenter study of safety and feasibility of primary stenting in acute myocardial infarction. Inhospital and 30 day results of the PAMI stent pilot trial. J Am Coll Cardiol 1998; 31: 23-30. Go to original source... Go to PubMed...
  4. Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999; 341: 1949-1956. Go to original source... Go to PubMed...
  5. Luepker RV, Raczynski JM, Osganian S, et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease. JAMA 2000; 284: 60-67. Go to original source... Go to PubMed...
  6. Weaver WD, Cerqueira M, Hallstrom AP, et al. Prehospital-initiated vs hospitalinitiated thrombolytic therapy: The Myocardial Infarction Triage and Intervention Trial. JAMA 1993; 270: 1211-1216. Go to original source...
  7. The European Myocardial Infarction Project Group. Prehospital thrombolytic therapy in patients with suspected acute myocardial infarction. N Engl J Med 1993; 329: 383-389. Go to original source... Go to PubMed...
  8. GREAT group. Feasibility, safety, and efficacy of domiciliary thrombolysis by general practitioners: Grampian Region Early Anistreplase Trial. BMJ 1992; 305:548-553. Go to original source... Go to PubMed...
  9. Roth A, Barbash GI, Hod H, et al. Should thrombolytic therapy be administered in the mobile intensive care unit in patients with evolving myocardial infarction? A pilot study. J Am Coll Cardiol 1990; 15: 932-936. Go to original source... Go to PubMed...
  10. Schofer J, Buttner J, Geng G, et al. Prehospital thrombolysis in acute myocardial infarction. Am J Cardiol 1990; 66: 1429-1433. Go to original source... Go to PubMed...
  11. Castaigne AD, Herve C, Duval-Moulin AM, et al. Prehospital use of APSAC: results of a placebo-controlled study. Am J Cardiol 1985; 64: 30A-33A. Go to original source... Go to PubMed...
  12. Castaigne AD, Duval AM, Dubois-Rande JL, Herve C, Jan F, Louvard Y. Prehospital administration of an-isoylated plasminogen streptokinase activator complex in acute myocardial infarction. Drugs 1987; 33(suppl 3): 231-234. Go to original source... Go to PubMed...
  13. Barbash GI, Roth A, Hod H, et al. Improved survival but not left ventricular function with early and prehospital treatment with tissue plasminogen activator in acute myocardial infarction. Am J Cardiol 1990; 66: 261-266. Go to original source... Go to PubMed...
  14. Boissel JP. The European Myocardial Infarction Project: an assessment of prehospital thrombolysis. Int J Cardiol 1995; 49(suppl): S29-S37. Go to original source... Go to PubMed...
  15. Gotsman M, Gilon D, Lotan C, et al. Very early thrombolysis in acute myocardial infarction: the Jerusalem experience. Kardiologia Polska 1996; 44: 6-16.
  16. McAleer B, Ruane B, Burke E, et al. Prehospital thrombolysis in a rural community: short- and long-term survival. Cardiovasc Drugs Ther 1992; 6: 369-372. Go to original source... Go to PubMed...
  17. McNeill AJ, Cunningham SR, Flannery DJ, et al. A double blind placebo controlled study of early and late administration of recombinant tissue plasminogen activator in acute myocardial infarction. Br Heart J 1989; 61: 316-321. Go to original source... Go to PubMed...
  18. Risenfors M, Gustavsson G, Ekstrom L, et al. Prehospital thrombolysis in suspected acute myocardial infarction: results from the TEAHAT Study. J Intern med Suppl 1991; 229: 3-10.
  19. Rozenman Y, Gotsman MS, Weiss AT, et al. Early intravenous thrombolysis in acute myocardial infarction: the Jerusalem experience. Int J Cardiol 1995; 49(suppl):S21-S28. Go to original source... Go to PubMed...
  20. Fibrinolytic Therapy Trialist (FTT) Collaborative Group:Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomised trials of more than 1 000 patients. Lancet 1994; 343: 311-322. Go to original source...
  21. Morrison LJ, Verbeek PR, McDonald AC, et al. Mortality and Prehospital Thrombolysis for Acute Myocardial Infarction. JAMA 2000; 283: 2686-2692. Go to original source... Go to PubMed...
  22. Morrow DA, Antman EM, Sayah A, et al. Evaluation of the time saved by prehospital initiation of reteplase for ST-elevation myocardial infarction. J Am Coll Cardiol 2002; 40: 71-77. Go to original source... Go to PubMed...
  23. Boersma E, Maas ACP, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348: 771-775. Go to original source... Go to PubMed...
  24. Rawles JM.Quantification of the benefit of earlier thrombolytic therapy: five-year results of the Grampian Region Early Anistreplase Trial (GREAT). J Am Coll Cardiol 1997; 30: 1181-1186. Go to original source... Go to PubMed...
  25. Stern R, Arntz HR. Prehospital thrombolysis in acute myocardial infarction. Europ J Emerg Med 1998; 5: 471-479. Go to original source...
  26. Weaver WD, Simes RJ, Betriu A, et al. Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review. JAMA 1997; 278: 2093-2098. Go to original source... Go to PubMed...
  27. Boersma E, Akkerhuis M, Simoons ML. Primary Angioplasty versus Thrombolysis for Acute Myocardial Infarction. N Engl J Med 2000; 342: 890. Go to original source... Go to PubMed...
  28. Zijlstra F, Hoortnje JCA, de Boer M-J, et al. Long-term benefit of primary angioplasty as compared with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1999; 341: 1413-1419. Go to original source... Go to PubMed...
  29. Bonnefoy E, Lapostolle F, Leizorovicz A, Steg G, et al. Primary angioplasty versus prehospital fibrinolysis in acute myocardial infarction: a randomised study. Lancet 2002; 360: 825-829. Go to original source... Go to PubMed...
  30. Dvořák K, Dvořák J. Systémová trombolýza streptokinázou u nemocných se srdečním infarktem v přednemocniční etapě. Cor Vasa 1994; 36: 53-56.
  31. Mareček V, Wiesner M.Vybrané aspekty postupu zdravotnických záchranných služeb u pacientů s akutním infarktem myokardu, 1. část. Interv Akut Kardiol 2003, v tisku.
  32. Fibrinolytic Therapy Trialists (FTT) Collaborative Group. Indications for fibrinolytic therapy in suspected acute myocardial infarction: collaborative overview of early mortality and major morbidity results from all randomized trials of more than 1 000 patients /published correction appears in Lancet 1994; 343: 742 / Lancet 1994; 343: 311-322. Go to original source...
  33. Whitbread M, Leah V, Bell T, et al. Recognition of ST elevation by paramedics. Energ Med 2002:66-67. Go to original source... Go to PubMed...
  34. McCrea WA, Saltissi S. Electrocardiogram interpretation in general practice: relevance to prehospital thrombolysis. Br Heart J 1993; 70: 219-225. Go to original source... Go to PubMed...
  35. O' Ŕourke MF, Cook A, Carroll G, et al. Accuracy of a portable interpretive ECG machine in diagnosis of acute evolving myocardial infarction. Aust NZ J Med 1992; 9-13.
  36. Aufderheide TP, Keelan MH, Hendley GE, et al. Milwaukee Prehospital Chest Pain Project - Phase I: Feasibility and Accuracy of Prehospital Thrombolytic Candidate Selection. Am J Cardiol 1992; 69: 991-996. Go to original source... Go to PubMed...
  37. Foster DB, Dufendach JH, Barkdoll CM, et al. Prehospital recognition of AMI using independent nurse paramedic 12-lead ECG evaluation. AM J Emerg Med 1994; 12: 25-31. Go to original source... Go to PubMed...
  38. Brügemann J, Meer J van der, Graeff PA de, Takens LH, Lie KI. Logistical problems in prehospital thrombolysis. Eur Heart J 1992; 13: 787-788. Go to original source... Go to PubMed...
  39. Kudenchuk PJ, Ho MT, Weaver WD, Litwin PE, Martin JS, Eisenberg MS, Hallstrom AP, Cobb LA, Kennedy JW. Accuracy of computer-Interpreted Electrocardiography in Selecting Patients for Thrombolytic Therapy. J Am Coll Cardiol 1991; 17: 1486-1491. Go to original source... Go to PubMed...
  40. Myers RBH Prehospital management of acute myocardial infarction: Electrocardiogram acquisition and interpretation, and thrombolysis by prehospital care providers. Can J Cardiol 1998; 14: 1231-1240.
  41. McMechan SR, Adgey AAJ. Optimal thrombolytic strategies for acute myocardial infarction-bolus administration. Q J Med 1998; 91: 719-725. Go to original source... Go to PubMed...
  42. Tsang TS, Califf RM, Stabbins AL et al. Incidence and impact on outcome of streptokinase allergy in the Gusto_I trial. Global Utilization of Streptokinase and t-PA in Occluded Coronary Arteries. Am J Cardiol 1997; 79: 1232-1235. Go to original source... Go to PubMed...
  43. Gemmill JD, Hogg KJ, Douglas JT, et al. The incidence and mechanism of hypotension following thrombolytic therapy for acute myocardial infarction with streptokinase-containing agents: lack of relationship to pretreatment streptokinase resistance. Eur Heart J 1993; 14: 819-825. Go to original source... Go to PubMed...
  44. Timmis, GC, Gangadharan V, Ramos RG, et al. Hemorrhage and the products of fibrinogen digestion after intracoronary administration of streptokinase. Circulation 1984; 69: 1146-1152. Go to original source... Go to PubMed...
  45. Hoffmeister HM, Szabo S, Kastner C, et al. Thrombolytic therapy in acute myocardial infarction: comparison of procoagulant effects of streptokinase and alteplase regimens with focus on the kallikrein system and plasmin. Circulation 1998; 98: 2527-2533. Go to original source... Go to PubMed...
  46. Widimsky P, Groch L, Zelizko M, et al. Multicentre randomized trial comparing transport to primary angioplasty vs immediate thrombolysis vs combined strategy for patients with acute myocardial infarction presenting to a community hospital without a catheterization laboratory. The PRAGUE study. Eur Heart J 2000; 21: 823-831. Go to original source... Go to PubMed...
  47. Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999; 354: 716-722.
  48. The Global Use of Strategies to Open Occluded Coronary Arteries (GUSTO III) Investigators. A comparison of reteplase with alteplase for acute myocardial infarction. N Engl J Med 1997; 337: 1118-1123. Go to original source... Go to PubMed...
  49. Juliard JM, Himbert D, Cristofini P, et al. A Matched Comparison of the Combination of Prehospital Thrombolysis and Standby Rescue Angioplasty With Primary Angioplasty. Am J Cardiol 1999; 83: 305-310. Go to original source... Go to PubMed...
  50. Loubeyre C, Lef?vre T, Louvard Y, et al. Outcome after combined reperfusion therapy for acute myocardial infarction, combining pre-hospital thrombolysis with immediate percutaneous coronary intervention and stent. Eur Heart J 2001; 22: 1128-1135. Go to original source... Go to PubMed...
  51. McFadden EP. Fibrinolysis and stenting in acute myocardial infarction: newlyweds distined for a "m? nage ? trois"? Eur Heart J 2001; 22: 1067-1069. Go to original source... Go to PubMed...
  52. Welsh RC, Ornato J, Armstrong PW. Prehospital management of acute ST-elevation myocardial infarction: A time for reappraisal in North America. Am Heart J 2003; 145: 1-8. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.